Inflammation and ovarian cancer
- 1 May 2012
- journal article
- review article
- Published by Elsevier BV in Cytokine
- Vol. 58 (2), 133-147
- https://doi.org/10.1016/j.cyto.2012.01.015
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Interleukin-6 as a Therapeutic Target in Human Ovarian CancerClinical Cancer Research, 2011
- TGF-β Blockade Controls Ascites by Preventing Abnormalization of Lymphatic Vessels in Orthotopic Human Ovarian Carcinoma ModelsClinical Cancer Research, 2011
- Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancerCancer, 2010
- NF-κB is involved in SHetA2 circumvention of TNF-α resistance, but not induction of intrinsic apoptosisAnti-Cancer Drugs, 2010
- Immune Response in Ovarian Cancer: How Is the Immune System Involved in Prognosis and Therapy: Potential for Treatment UtilizationClinical and Developmental Immunology, 2010
- In situStimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer–Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory CellsCancer Research, 2009
- Prediagnostic symptoms of ovarian carcinoma: A case-control studyGynecologic Oncology, 2009
- Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3International Journal of Cancer, 2009
- Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis: Integrative Cancer Research, 2009
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomasBritish Journal of Cancer, 2008